0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Screening Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-2I7206
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Screening Market Insights and Forecast to 2028
BUY CHAPTERS

Global Drug Screening Market Research Report 2025

Code: QYRE-Auto-2I7206
Report
August 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Screening Market Size

The global market for Drug Screening was valued at US$ 4797 million in the year 2024 and is projected to reach a revised size of US$ 6988 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Drug Screening Market

Drug Screening Market

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Screening.
The Drug Screening market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Screening manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Screening Market Report

Report Metric Details
Report Name Drug Screening Market
Accounted market size in year US$ 4797 million
Forecasted market size in 2031 US$ 6988 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Immunoassay Analyzers
  • Chromatography
  • Breath Analyzers
  • Rapid Testing Devices
  • Assay Kits and Reagents
Segment by Application
  • Hospitals
  • Research Institute
  • Biotechnology & Pharmaceutical Companies
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drug Screening Market growing?

Ans: The Drug Screening Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Drug Screening Market size in 2031?

Ans: The Drug Screening Market size in 2031 will be US$ 6988 million.

Who are the main players in the Drug Screening Market report?

Ans: The main players in the Drug Screening Market are Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific

What are the Application segmentation covered in the Drug Screening Market report?

Ans: The Applications covered in the Drug Screening Market report are Hospitals, Research Institute, Biotechnology & Pharmaceutical Companies, Others

What are the Type segmentation covered in the Drug Screening Market report?

Ans: The Types covered in the Drug Screening Market report are Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents

1 Drug Screening Market Overview
1.1 Product Definition
1.2 Drug Screening by Type
1.2.1 Global Drug Screening Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immunoassay Analyzers
1.2.3 Chromatography
1.2.4 Breath Analyzers
1.2.5 Rapid Testing Devices
1.2.6 Assay Kits and Reagents
1.3 Drug Screening by Application
1.3.1 Global Drug Screening Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Biotechnology & Pharmaceutical Companies
1.3.5 Others
1.4 Global Drug Screening Market Size Estimates and Forecasts
1.4.1 Global Drug Screening Revenue 2020-2031
1.4.2 Global Drug Screening Sales 2020-2031
1.4.3 Global Drug Screening Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Screening Market Competition by Manufacturers
2.1 Global Drug Screening Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Screening Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Screening Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Screening, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Screening, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Screening, Product Type & Application
2.7 Global Key Manufacturers of Drug Screening, Date of Enter into This Industry
2.8 Global Drug Screening Market Competitive Situation and Trends
2.8.1 Global Drug Screening Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Screening Players Market Share by Revenue
2.8.3 Global Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Screening Market Scenario by Region
3.1 Global Drug Screening Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Screening Sales by Region: 2020-2031
3.2.1 Global Drug Screening Sales by Region: 2020-2025
3.2.2 Global Drug Screening Sales by Region: 2026-2031
3.3 Global Drug Screening Revenue by Region: 2020-2031
3.3.1 Global Drug Screening Revenue by Region: 2020-2025
3.3.2 Global Drug Screening Revenue by Region: 2026-2031
3.4 North America Drug Screening Market Facts & Figures by Country
3.4.1 North America Drug Screening Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Screening Sales by Country (2020-2031)
3.4.3 North America Drug Screening Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Screening Market Facts & Figures by Country
3.5.1 Europe Drug Screening Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Screening Sales by Country (2020-2031)
3.5.3 Europe Drug Screening Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Screening Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Screening Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Screening Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Screening Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Screening Market Facts & Figures by Country
3.7.1 Latin America Drug Screening Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Screening Sales by Country (2020-2031)
3.7.3 Latin America Drug Screening Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Screening Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Screening Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Screening Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Screening Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Screening Sales by Type (2020-2031)
4.1.1 Global Drug Screening Sales by Type (2020-2025)
4.1.2 Global Drug Screening Sales by Type (2026-2031)
4.1.3 Global Drug Screening Sales Market Share by Type (2020-2031)
4.2 Global Drug Screening Revenue by Type (2020-2031)
4.2.1 Global Drug Screening Revenue by Type (2020-2025)
4.2.2 Global Drug Screening Revenue by Type (2026-2031)
4.2.3 Global Drug Screening Revenue Market Share by Type (2020-2031)
4.3 Global Drug Screening Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Screening Sales by Application (2020-2031)
5.1.1 Global Drug Screening Sales by Application (2020-2025)
5.1.2 Global Drug Screening Sales by Application (2026-2031)
5.1.3 Global Drug Screening Sales Market Share by Application (2020-2031)
5.2 Global Drug Screening Revenue by Application (2020-2031)
5.2.1 Global Drug Screening Revenue by Application (2020-2025)
5.2.2 Global Drug Screening Revenue by Application (2026-2031)
5.2.3 Global Drug Screening Revenue Market Share by Application (2020-2031)
5.3 Global Drug Screening Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Drug Screening Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Express Diagnostics
6.2.1 Express Diagnostics Company Information
6.2.2 Express Diagnostics Description and Business Overview
6.2.3 Express Diagnostics Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Express Diagnostics Drug Screening Product Portfolio
6.2.5 Express Diagnostics Recent Developments/Updates
6.3 Laboratory Corporation of America
6.3.1 Laboratory Corporation of America Company Information
6.3.2 Laboratory Corporation of America Description and Business Overview
6.3.3 Laboratory Corporation of America Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Laboratory Corporation of America Drug Screening Product Portfolio
6.3.5 Laboratory Corporation of America Recent Developments/Updates
6.4 MPD
6.4.1 MPD Company Information
6.4.2 MPD Description and Business Overview
6.4.3 MPD Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MPD Drug Screening Product Portfolio
6.4.5 MPD Recent Developments/Updates
6.5 Quest Diagnostics
6.5.1 Quest Diagnostics Company Information
6.5.2 Quest Diagnostics Description and Business Overview
6.5.3 Quest Diagnostics Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Quest Diagnostics Drug Screening Product Portfolio
6.5.5 Quest Diagnostics Recent Developments/Updates
6.6 Roche Diagnostics
6.6.1 Roche Diagnostics Company Information
6.6.2 Roche Diagnostics Description and Business Overview
6.6.3 Roche Diagnostics Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche Diagnostics Drug Screening Product Portfolio
6.6.5 Roche Diagnostics Recent Developments/Updates
6.7 Shimadzu
6.7.1 Shimadzu Company Information
6.7.2 Shimadzu Description and Business Overview
6.7.3 Shimadzu Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shimadzu Drug Screening Product Portfolio
6.7.5 Shimadzu Recent Developments/Updates
6.8 Siemens Healthcare
6.8.1 Siemens Healthcare Company Information
6.8.2 Siemens Healthcare Description and Business Overview
6.8.3 Siemens Healthcare Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Siemens Healthcare Drug Screening Product Portfolio
6.8.5 Siemens Healthcare Recent Developments/Updates
6.9 Thermo Fisher Scientific
6.9.1 Thermo Fisher Scientific Company Information
6.9.2 Thermo Fisher Scientific Description and Business Overview
6.9.3 Thermo Fisher Scientific Drug Screening Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Thermo Fisher Scientific Drug Screening Product Portfolio
6.9.5 Thermo Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Screening Industry Chain Analysis
7.2 Drug Screening Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Screening Production Mode & Process Analysis
7.4 Drug Screening Sales and Marketing
7.4.1 Drug Screening Sales Channels
7.4.2 Drug Screening Distributors
7.5 Drug Screening Customer Analysis
8 Drug Screening Market Dynamics
8.1 Drug Screening Industry Trends
8.2 Drug Screening Market Drivers
8.3 Drug Screening Market Challenges
8.4 Drug Screening Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug Screening Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Screening Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Screening Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Screening Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Screening Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Screening Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Screening Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Screening Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Screening, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Screening, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Screening, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Screening, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Screening as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Screening Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Screening Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Screening Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Screening Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Screening Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Screening Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Screening Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Screening Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Screening Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Screening Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Screening Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Screening Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Screening Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Screening Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Screening Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Screening Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Screening Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Screening Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Screening Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Screening Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Screening Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Screening Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Screening Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Screening Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Screening Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Screening Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Screening Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Screening Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Screening Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Screening Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug Screening Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug Screening Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Screening Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Screening Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Screening Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Screening Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Screening Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Screening Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Screening Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Screening Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug Screening Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Drug Screening Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Express Diagnostics Company Information
 Table 76. Express Diagnostics Description and Business Overview
 Table 77. Express Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Express Diagnostics Drug Screening Product
 Table 79. Express Diagnostics Recent Developments/Updates
 Table 80. Laboratory Corporation of America Company Information
 Table 81. Laboratory Corporation of America Description and Business Overview
 Table 82. Laboratory Corporation of America Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Laboratory Corporation of America Drug Screening Product
 Table 84. Laboratory Corporation of America Recent Developments/Updates
 Table 85. MPD Company Information
 Table 86. MPD Description and Business Overview
 Table 87. MPD Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. MPD Drug Screening Product
 Table 89. MPD Recent Developments/Updates
 Table 90. Quest Diagnostics Company Information
 Table 91. Quest Diagnostics Description and Business Overview
 Table 92. Quest Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Quest Diagnostics Drug Screening Product
 Table 94. Quest Diagnostics Recent Developments/Updates
 Table 95. Roche Diagnostics Company Information
 Table 96. Roche Diagnostics Description and Business Overview
 Table 97. Roche Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Roche Diagnostics Drug Screening Product
 Table 99. Roche Diagnostics Recent Developments/Updates
 Table 100. Shimadzu Company Information
 Table 101. Shimadzu Description and Business Overview
 Table 102. Shimadzu Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shimadzu Drug Screening Product
 Table 104. Shimadzu Recent Developments/Updates
 Table 105. Siemens Healthcare Company Information
 Table 106. Siemens Healthcare Description and Business Overview
 Table 107. Siemens Healthcare Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Siemens Healthcare Drug Screening Product
 Table 109. Siemens Healthcare Recent Developments/Updates
 Table 110. Thermo Fisher Scientific Company Information
 Table 111. Thermo Fisher Scientific Description and Business Overview
 Table 112. Thermo Fisher Scientific Drug Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Thermo Fisher Scientific Drug Screening Product
 Table 114. Thermo Fisher Scientific Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Drug Screening Distributors List
 Table 118. Drug Screening Customers List
 Table 119. Drug Screening Market Trends
 Table 120. Drug Screening Market Drivers
 Table 121. Drug Screening Market Challenges
 Table 122. Drug Screening Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Screening
 Figure 2. Global Drug Screening Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Screening Market Share by Type: 2024 & 2031
 Figure 4. Immunoassay Analyzers Product Picture
 Figure 5. Chromatography Product Picture
 Figure 6. Breath Analyzers Product Picture
 Figure 7. Rapid Testing Devices Product Picture
 Figure 8. Assay Kits and Reagents Product Picture
 Figure 9. Global Drug Screening Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Drug Screening Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Research Institute
 Figure 13. Biotechnology & Pharmaceutical Companies
 Figure 14. Others
 Figure 15. Global Drug Screening Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Drug Screening Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Drug Screening Sales (2020-2031) & (K Units)
 Figure 18. Global Drug Screening Average Price (US$/Unit) & (2020-2031)
 Figure 19. Drug Screening Report Years Considered
 Figure 20. Drug Screening Sales Share by Manufacturers in 2024
 Figure 21. Global Drug Screening Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Drug Screening Players: Market Share by Revenue in Drug Screening in 2024
 Figure 23. Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Drug Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Drug Screening Sales Market Share by Country (2020-2031)
 Figure 26. North America Drug Screening Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Drug Screening Sales Market Share by Country (2020-2031)
 Figure 30. Europe Drug Screening Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Drug Screening Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Drug Screening Revenue Market Share by Region (2020-2031)
 Figure 38. China Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Drug Screening Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Drug Screening Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Drug Screening Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Drug Screening Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Drug Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Drug Screening by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Drug Screening by Type (2020-2031)
 Figure 60. Global Drug Screening Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Drug Screening by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Drug Screening by Application (2020-2031)
 Figure 63. Global Drug Screening Price (US$/Unit) by Application (2020-2031)
 Figure 64. Drug Screening Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India